Amgen Inc. buy tamam
Start price
16.06.17
/
50%
€147.78
Target price
11.09.17
€164.89
Performance (%)
12.61%
End price
11.09.17
€165.38
Summary
This prediction ended on 11.09.17 with a price of €165.38. The BUY prediction by tamam finished with a performance of 12.61%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -4.871% | -4.871% | 16.196% | 39.313% |
| iShares Core DAX® | 1,35 % | 0,93 % | 6,81 % | 52,45 % |
| iShares Nasdaq 100 | 3,28 % | 4,99 % | 41,20 % | 93,45 % |
| iShares Nikkei 225® | 7,43 % | 16,60 % | 70,50 % | 80,90 % |
| iShares S&P 500 | 1,70 % | 2,24 % | 27,28 % | 67,69 % |
Comments by tamam for this prediction
In the thread Amgen Inc. diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 16.06.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 182.81$ zu.
(Zielkurs erreicht)


